GlassScriptPhysician profile
Stephen Raskin
NPI 1730125980
$109,382.12
in general payments reported to CMS, 2019-2025
17 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83K · 2020: $26K · 2021: $165 · 2022: $14.12 · 2023: $144 · 2024: $167 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.46 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $81,498.50 | 2019-2021 | |
| Amgen INC. | $11,786.89 | 2019-2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $7,559.19 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $6,509.71 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $1,156.01 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $237.90 | 2023-2025 | |
| Alnylam Pharmaceuticals INC. | $140.00 | 2025 | |
| Akcea Therapeutics, INC. | $121.36 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.03 | 2024-2025 | |
| Baxter Healthcare | $75.77 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Esperion Therapeutics, INC. | $71.45 | 2020-2024 | Nexletol |
| Irhythm Technologies, INC. | $40.10 | 2019-2020 | |
| Biotronik INC. | $22.77 | 2023 | Biomonitor |
| Boston Scientific Corporation | $20.49 | 2020 | |
| Medtronic Vascular, INC. | $15.88 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.43 | 2024 | Xarelto |
| Preventice Services, LLC | $14.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Raskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.